Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various unive... Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.09 | -5.88235294118 | 1.53 | 1.55 | 1.36 | 51366 | 1.44155167 | CS |
| 4 | 0.13 | 9.92366412214 | 1.31 | 1.56 | 1.1 | 114172 | 1.33007225 | CS |
| 12 | -0.09 | -5.88235294118 | 1.53 | 1.7 | 1.1 | 362474 | 1.28434764 | CS |
| 26 | -0.41 | -22.1621621622 | 1.85 | 2.23 | 1.1 | 242331 | 1.44203736 | CS |
| 52 | -1.15 | -44.4015444015 | 2.59 | 3.38 | 1.1 | 144373 | 1.60529255 | CS |
| 156 | -2.46 | -63.0769230769 | 3.9 | 4.16 | 0.962777 | 260535 | 2.50714494 | CS |
| 260 | -11.69 | -89.0327494288 | 13.13 | 34.71 | 0.962777 | 259397 | 8.24264042 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
